• Shopping cart is empty.

    The International Society for Aerosols in Medicine

    Bernhard Müllinger

    Bernhard Müllinger


    Bernhard Müllinger is Chief Operating Officer at Resyca BV and General Manager at Resyca GmbH. Resyca BV is a joint venture from Recipharm AB and Medspray BV developing and exploiting a novel soft mist spray nozzle technology for pharmaceutical applications.

    His primary research focus is the development of drug device combination products using enhanced aerosol delivery technologies. Since 25 years, he is working in interdisciplinary development teams on novel inhalation technologies, deposition modelling, aerosol delivery strategies, patient compliance management and in vitro testing of inhalation products. In clinical research and development programs, he is working on the improvement of inhalation treatment of asthma, pulmonary hypertension, vaccination, influenza, cystic fibrosis and COPD and worked here with small molecules, peptides and proteins.

    Bernhard started with aerosols in 1995 at the Helmholtz-Zentrum Munich with Prof. Joachim Heyder working on optimization of particle deposition and environmental aerosol research. From there he moved to a research group at Asklepios Clinics developing novel pulmonary diagnostic technologies. He joined Dr Gerhard Scheuch in 2000 to build up a respiratory specialty CRO and a respiratory drug/device development company, which led to successful products and several spin-off companies.

    He has been a member of ISAM since 2002.